- Quarter end
- 30 Jun 2026
- the date the book describes
- Filed
- 2 Sep 2026
- latest of these filings; the earliest 3 Aug 2026
- Managers listing it
- 18
- at least, of 95 tracked, among listed positions
- Comparable managers
- 91
- filed both Q1 2026 and Q2 2026; 1 listed it in both
- Shares listed
- 2,326,749
- combined, among listed positions
- Reported value
- $25m
- combined, at the quarter end
Among the 91 comparable managers: 15 buyers (opened or added shares) and 5 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +383,468.
Managers listing MED in Q2 2026
18 of 18 holders
Largest increases and reductions, by shares
Increases
- Marshall Wace LLPnew position · 241,649 shares now+241,649
- Two Sigma Investments LPexisting position · 481,381 shares now+143,223
- AQR Capital Management LLCexisting position · 236,434 shares now+90,859
- Tudor Investment Corpnew position · 76,031 shares now+76,031
- Citadel Advisors LLCnew position · 56,350 shares now+56,350
Reductions
- D. E. Shaw & Co.existing position · 92,345 shares now-68,219
- Schonfeld Strategic Advisors LLCexisting position · 12,367 shares now-30,185
- Invesco Ltdexisting position · 13,315 shares now-19,461
New positions and exits
New (7)
Exited (2)
- Man Group PLCwas $2.4m
- AllianceBernstein LPwas $292k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q3 2013 | 1 | $1.7m | n.a. | n.a. |
| Q4 2013 | 1 | $4.1m | n.a. | n.a. |
| Q1 2014 | 2 | $22m | n.a. | n.a. |
| Q2 2014 | 2 | $32m | n.a. | n.a. |
| Q3 2014 | 2 | $36m | n.a. | n.a. |
| Q4 2014 | 3 | $37m | n.a. | n.a. |
| Q1 2015 | 2 | $31m | n.a. | n.a. |
| Q2 2015 | 3 | $34m | n.a. | n.a. |
| Q3 2015 | 1 | $20m | n.a. | n.a. |
| Q4 2015 | 4 | $49m | n.a. | n.a. |
| Q1 2016 | 3 | $27m | n.a. | n.a. |
| Q2 2016 | 4 | $62m | n.a. | n.a. |
| Q3 2016 | 4 | $74m | n.a. | n.a. |
| Q4 2016 | 3 | $91m | n.a. | n.a. |
| Q1 2017 | 5 | $106m | n.a. | n.a. |
| Q2 2017 | 4 | $98m | n.a. | n.a. |
| Q3 2017 | 4 | $137m | n.a. | n.a. |
| Q4 2017 | 5 | $136m | n.a. | n.a. |
| Q1 2018 | 8 | $185m | n.a. | n.a. |
| Q2 2018 | 8 | $313m | n.a. | n.a. |
| Q3 2018 | 9 | $413m | n.a. | n.a. |
| Q4 2018 | 9 | $236m | n.a. | n.a. |
| Q1 2019 | 10 | $227m | n.a. | n.a. |
| Q2 2019 | 8 | $170m | n.a. | n.a. |
| Q3 2019 | 11 | $226m | n.a. | n.a. |
| Q4 2019 | 9 | $292m | n.a. | n.a. |
| Q1 2020 | 6 | $154m | n.a. | n.a. |
| Q2 2020 | 7 | $330m | n.a. | n.a. |
| Q3 2020 | 11 | $327m | n.a. | n.a. |
| Q4 2020 | 8 | $341m | n.a. | n.a. |
| Q1 2021 | 9 | $264m | n.a. | n.a. |
| Q2 2021 | 11 | $393m | n.a. | n.a. |
| Q3 2021 | 7 | $204m | n.a. | n.a. |
| Q4 2021 | 6 | $199m | n.a. | n.a. |
| Q1 2022 | 7 | $153m | n.a. | n.a. |
| Q2 2022 | 5 | $149m | n.a. | n.a. |
| Q3 2022 | 4 | $79m | n.a. | n.a. |
| Q4 2022 | 5 | $78m | n.a. | n.a. |
| Q1 2023 | 6 | $73m | n.a. | n.a. |
| Q2 2023 | 5 | $67m | n.a. | n.a. |
| Q3 2023 | 3 | $57m | n.a. | n.a. |
| Q4 2023 | 2 | $51m | 2 | 0 |
| Q1 2024 | 2 | $32m | 2 | 0 |
| Q2 2024 | 1 | $7.4m | 1 | 0 |
| Q3 2024 | 1 | $5.5m | 0 | 1 |
| Q1 2025 | 1 | $5.2m | 1 | 0 |
| Q1 2026 | 1 | $313k | 7 | 8 |
| Q2 2026 | 1 | $348k | 15 | 5 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
MED and PM →MED and KO →MED and COST →Choose a stock to compare with MED →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own MED, latest filings →Back to the 13F Explorer →